Publications (41) Gorka Alkorta Aranburu publications

2024

  1. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma

    Scientific Reports, Vol. 14, Núm. 1

  2. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration

    Nature Communications, Vol. 15, Núm. 1

  3. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Next-generation sequencing improves precision medicine in hearing loss

    Frontiers in Genetics, Vol. 14

  2. Primary trimethylaminuria syndrome: more than an unpleasant odor

    International Journal of Dermatology

2022

  1. Familial primary cutaneous amyloidosis: Caspase activation may be involved in amyloid formation

    Experimental Dermatology

  2. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

    Journal of Personalized Medicine, Vol. 12, Núm. 11

  3. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial

    Cancers, Vol. 14, Núm. 20

  4. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures

    Gut, Vol. 71, Núm. 6, pp. 1141-1151

  5. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

2021

  1. Applying next generation sequencing to an early detection of hearing loss program

    JOURNAL OF PEDIATRICS RESEARCH REVIEWS & REPORTS, Vol. 3, Núm. 1, pp. 1 - 7

  2. Machine learning-based approach highlights the use of a genomic variant profile for precision medicine in ovarian failure

    Journal of Personalized Medicine, Vol. 11, Núm. 7

2020

  1. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348

2019

  1. Distrofias musculares

    Principios de bioquímica clínica y patología molecular (Elsevier España), pp. 405-410

  2. Genotyping and Sequencing

    Principles of Nutrigenetics and Nutrigenomics: Fundamentals of Individualized Nutrition (Elsevier), pp. 33-39

  3. NGS data analysis process

    Principles of Nutrigenetics and Nutrigenomics: Fundamentals of Individualized Nutrition (Elsevier), pp. 33-39

  4. The dynamic use of EGFR mutation analysis in cell-free DNA as a follow-up biomarker during different treatment lines in non-small-cell lung cancer patients

    Disease Markers, Vol. 2019

2018

  1. Does arterial hypertension influence the onset of Huntington’s disease?

    PLoS ONE, Vol. 13, Núm. 5

  2. Pancreatic histopathology of human monogenic diabetes due to causal variants in KCNJ11, HNF1A, GATA6, and LMNA

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 35-45

  3. Reprogramming human T cell function and specificity with non-viral genome targeting

    Nature, Vol. 559, Núm. 7714, pp. 405-409